In silico medicine promises to accelerate medical device and pharmaceutical innovation, while reigning in the spiraling cost of healthcare.
This white paper explores how simulation and the creation of virtual humans can help researchers and doctors deliver cost-effective, patient-specific treatment plans.
These disruptions are real and are happening now. The question is, are you ready?
